Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Homocisteína, metabolismo y determinantes higienicodietéticos
Información de la revista
Vol. 51. Núm. 8.
Páginas 458-463 (Octubre 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 51. Núm. 8.
Páginas 458-463 (Octubre 2004)
Acceso a texto completo
Homocisteína, metabolismo y determinantes higienicodietéticos
Homocysteine, Metabolism And Dietary Factors
Visitas
...
D.A. De Luis
Autor para correspondencia
Dadluis@yahoo.es

Correspondencia: Dr. D.A. de Luis. Instituto de Endocrinología y Nutrición. Los Perales, 16 (urbanización Las Aceñas). 47130 Simancas. Valladolid. España.
, N. Fernández, R. Aller
Servicio de Endocrinología y Nutrición. Unidad de Apoyo a la Investigación. Hospital Universitario Río Hortega. Instituto de Endocrinología y Nutrición. Facultad de Medicina. Valladolid. España
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas

Homocysteine (Hcy) is a sulfur-containing amino acid with a free thiol group that is not found in dietary proteins but is exclusively produced as an intermediate product of methionine and cysteine metabolism. Therefore, the only source of this amino acid is methionine. Hcy concentration is secondary to complex interaction among multiple external and genetics factors and is modified by a series of physiological determinants such as age, sex, menopause, pregnancy and race. Genetic defects can also modify Hcy concentrations and 3 defects have been described: cystathionine-β-synthase deficiency (CBS), N5,N10- methylenetetrahydrofolate reductase deficiency (MTHFR) and methionine synthase deficiency (MS). Among the dietary factors that can influence Hcy concentrations are vitamin status, smoking and alcohol consumption, dietary protein intake, and exercise. The consumption of certain drugs, as well as manipulation of the sample obtained, can also influence Hcy levels.

All of these factors should be taken into account when determining Hcy concentrations.

Palabras clave:
Dieta
Homocisteína
Metabolismo
Key words:
Diet
Homocysteine
Metabolism

La homocisteína es un aminoácido azufrado caracterizado por la presencia de un grupo tiol libre, que no está presente en las proteínas de la dieta sino que se forma exclusivamente como producto intermediario en el metabolismo de la metionina a cisteína. Por tanto, la única fuente de homocisteína en el organismo es el aminoácido esencial metionina. La concentración de homocisteína total es producto de una compleja interacción entre múltiples factores genéticos y ambientales. En su concentración influyen una serie de determinantes fisiológicos, como la edad, el sexo, la menopausia, el embarazo y la raza. Los defectos genéticos también pueden influir en las concentraciones de homocisteína; existen 3 déficit descritos: deficiencia de cistationina-β-sintasa, deficiencia de la N5,N10-metilentetrahidrofolato reductasa y deficiencia de metionina sintasa. Dentro de los determinantes dietéticos que pueden influir en los valores de homocisteína podemos citar el estatus vitamínico, el consumo de alcohol y tabaco, el contenido de metionina de las proteínas de la dieta y el ejercicio. El consumo de determinados fármacos, así como la manipulación de la muestra obtenida, también puede influir en las concentraciones de este aminoácido.

Es necesario tener en cuenta todos estos determinantes higienicodietéticos a la hora de valorar una determinación aislada de homocisteína.

El Texto completo está disponible en PDF
Biblografía
[1.]
J.D. Finkelstein.
Methionine metabolism in mammals.
J Nutr Biochem, 1 (1990), pp. 228-237
[2.]
P.M. Ueland.
Homocysteine species as components of plasma redox thiol status.
Clin Chem, 41 (1995), pp. 340-342
[3.]
M.A. Mansoor, A.M. Svardal, J. Schneede, P.M. Ueland.
Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men.
Clin Chem, 38 (1992), pp. 1316-1321
[4.]
H. Refsum, S. Helland, P.M. Ueland.
Radioenzymic determination of homocysteine in plasma and urine.
Clin Chem, 31 (1985), pp. 624-628
[5.]
J.M. Mato, L. Alvarez, P. Ortiz, M.A. Pajares.
S-Adenosylmethionine synthesis: molecular mechanism and clinical implications.
Pharmacol Ther, 73 (1997), pp. 265-280
[6.]
S-S Kang, P.W.K. Wong, M.R. Malinow.
Hyperhomocystein(e)mia as a risk factor for oclussive vascular disease.
Ann Rev Nutr, 12 (1992), pp. 279-298
[7.]
O. Nygard, S.E. Vollset, H. Refsum, I. Stensvold, A. Tverdal, J.E. Nordrehaug, et al.
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.
JAMA, 274 (1995), pp. 1526-1533
[8.]
F. Wollesen, L. Brattstrom, H. Refsum, P.M. Ueland, L. Berglund, C. Berne.
Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
[9.]
J.B. Ubbink.
Should all elderly people receive folate supplements?.
Drugs Aging, 13 (1998), pp. 415-420
[10.]
R. Carmel.
Cobalamin, the stomach, and aging.
Am J Clin Nutr, 66 (1997), pp. 750-759
[11.]
L. Brattstrom, A. Lindgren, B. Israelsson, A. Andersson, B. Hultberg.
Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects.
J Intern Med, 236 (1994), pp. 633-641
[12.]
A. Andersson, A. Isaksson, B. Hultberg.
Homocysteine export from erythrocytes and its implication from plasma sampling.
Clin Chem, 38 (1992), pp. 1311-1315
[13.]
R. Carmel, R. Green, D.W. Jacobsen, K. Rasmussen, M. Florea, C. Azen.
Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities.
Am J Clin Nutr, 70 (1999), pp. 904-910
[14.]
J.B. Ubbink, W.J. Vermaak, A. Van der Merwe, P.J. Beckr.
The effect of blood sample aging and food consumption on plasma total homocysteine levels.
Clin Chem Acta, 207 (1992), pp. 119-128
[15.]
H. Refsum, P.M. Ueland, O. Nygard, S.E. Vollset.
Homocysteine and cardiovascular disease.
Annu Rev Med, 49 (1998), pp. 31-62
[16.]
M.J. Van der Moren.
Homocysteine: influences of menopausal status and postmenopausal hormone replacement therapy.
Neeth J Med, 52 (1998), pp. 44
[17.]
V. Mijatovic, C. Netelenbos, M.J. Van der Mooren, G.W. De Valk-de Roo, C. Jakobs, P. Kenemans.
A randomized controlled study of the effects of 17-βÀ-estradiol-dydrogesterone on plasma homocysteine in posmenopausal women.
Obstet Gynecol, 91 (1998), pp. 432-436
[18.]
R.A. Hegele, C. Tully, T.K. Young, P.W. Connelly.
V677 mutation of methylenetetrahydrofolate reductase and cardiovascular disease in Canadian Inuit.
Lancet, 349 (1997), pp. 1221-1222
[19.]
R.F. Franco, A.G. Araujo, J.F. Guerreiro, J. Elion, M.A. Zago.
Analysis of the 677 Cš¨T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups.
Thromb Haemost, 79 (1998), pp. 119-121
[20.]
M. Hiroyuki.
Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as risk factor for coronary artery disease.
Circulation, 95 (1997), pp. 2032-2036
[21.]
O. Nygard, H. Refsum, P.M. Ueland, S.E. Vollset.
Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.
Am J Clin Nutr, 67 (1998), pp. 263-270
[22.]
J.B. Ubbink, A. Van der Merwe, R. Delport, R.H. Allen, S.P. Stabler, R. Riezler, et al.
The effect of a subnormal vitamin B6 status on homocysteine metabolism.
J Clin Invest, 98 (1996), pp. 177-184
[23.]
C. Nagata, H. Shimizu, R. Takami, M. Hayashi, N. Takeda, K. Yasuda.
Soy product intake is inversely associated with serum homocysteine level in premmenopausal Japanese women.
J Nutr, 133 (2003), pp. 797-800
[24.]
I.M. Graham, L.E. Daly, H.M. Refsum, K. Robinson, L.E. Brattstrom, P.M. Ueland, et al.
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
JAMA, 277 (1997), pp. 1775-1781
[25.]
V. Ganji, M.R. Kafai.
Third National Health and Nutrition Examination Survey. Demographic, helath, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Helth and Nutrition Examination Survey, 1988-1994.
Am J Clin Nutr, 77 (2003), pp. 826-833
[26.]
A.B. Guttmorsen, J. Schneede, T. Fiskerstrand.
Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.
J Nutr, 124 (1994), pp. 1934-1941
[27.]
M. Den Heijer, G.M. Bos, I.A. Brouwer, W.B. Gerrits, H.J. Blom.
Variability of the methionine loading test: no efect of a low protein diet.
Ann Clin Biochem, 33 (1996), pp. 551-554
[28.]
R.Z. Stolzenberg-Solomon, E.R. Miller 3rd, M.G. Maguire, J. Selhub, L.J. Appel.
Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population.
Am J Clin Nutr, 69 (1999), pp. 467-475
[29.]
J. Mann, N. Dudman, X.W. Guo, P. Clarke, J. Mann, J.F. Simpson, et al.
The effect of diet on homocysteine levels in healthy male subjects.
Neth J Med, 52 (1998), pp. S10
[30.]
W. Herrmann, H. Schorr, R. Obeid, J. Geisel.
Vitamin B12 status, particularly holotranscobalamin II and methylmalonic acid concentracions, and hyperhomocysteinemia in vegetarians.
Am J Clin Nutr, 78 (2003), pp. 131-136
[31.]
P. Verhoef, W.J. Pasman, T. Van Vliet, R. Urgert, M.B. Katan.
Contribution of caffeine to the homocysteine-raising effect of coffe: a randomized controlled trial in humans.
Am J Clin Nutr, 76 (2002), pp. 1244-1248
[32.]
C. Bergmark, M.A. Mansoor, J. Swedenborg, U. De Faire, A.M. Svardal, P.M. Ueland.
Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50-effect of smoking and extent of disease.
Eur J Vasc Surg, 7 (1993), pp. 391-396
[33.]
A.M. Preston.
Cigarette smoking-nutritional implications.
Prog Food Nutr Sci, 15 (1991), pp. 183-217
[34.]
J.P. Eiserich, A. Van der Vliet, G.J. Handelman, B. Halliwell, C.E. Cross.
Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction.
Am J Clin Nutr, 62 (1995), pp. S1490-S1500
[35.]
S.E. Vollset, O. Nygard, G. Kvale, et al.
The Hordaland Homocysteine Study lifestyle and total plasma homocysteine in Western Norway.
Homocysteine metabolism: from basic science to clinical medicine, pp. 177-182
[36.]
D.A. De Luis, N. Fernandez, R. Aller, M. Arranz, O. Izaola.
Relation between total homocysteine levels and beer consumption in diabetics type 2 patients.
Annals of Nutrition, 47 (2003), pp. 119-123
[37.]
L.I. Mennen, G.P. De Courcy, J.C. Guilland, V. Ducros, M. Zarebska, S. Bertrais, et al.
Relation between homocysteine concentrations and the consumption of different types of alcoholic beberages: the French Supplementation with Antioxidant Vitamins and Minerals Study.
Am J Clin Nutr, 78 (2003), pp. 334-338
[38.]
P.M. Ueland, H. Refsum, S.P. Stabler, et al.
Total homocysteine in plasma or serum. Methods and clinical applications.
Clin Chem, 39 (1993), pp. 1764-1779
[39.]
H. Refsum, T. Fiskerstrand, A.B. Guttormsen, P.M. Ueland.
Assessment of homocysteine status.
J Inher Metab Dis, 20 (1997), pp. 286-294
[40.]
K. Rasmussen, J. Moller, M. Lyngbak.
Withinperson variation of plasma homocysteine and effects of posture and tourniquet application.
Clin Chem, 45 (1999), pp. 1850-1855
Copyright © 2004. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos